Robeco Institutional Asset Management B.V. Eli Lilly & CO Transaction History

Robeco Institutional Asset Management B.V.

  • $49.7 Billion
  • Q3 2024

A detailed history of Robeco Institutional Asset Management B.V. transactions in Eli Lilly & CO stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 826,944 shares of LLY stock, worth $658 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares
826,944
Previous 722,143 14.51%
Holding current value
$658 Million
Previous $654 Million 12.05%
% of portfolio
1.47%
Previous 1.42%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
BUY
$772.14 - $960.02 $80.9 Million - $101 Million
104,801 Added 14.51%
826,944 $733 Million
Q2 2024

Jul 22, 2024
SELL
$724.87 - $909.04 $41.7 Million - $52.3 Million
-57,552 Reduced 7.38%
722,143 $654 Million
Q1 2024

Apr 24, 2024
BUY
$592.2 - $792.28 $65.6 Million - $87.8 Million
110,775 Added 16.56%
779,695 $607 Million
Q4 2023

Feb 14, 2024
BUY
$525.19 - $619.13 $134 Million - $159 Million
256,057 Added 62.02%
668,920 $390 Million
Q4 2023

Feb 08, 2024
SELL
$525.19 - $619.13 $218 Million - $256 Million
-414,209 Reduced 50.08%
412,863 $669 Million
Q3 2023

Oct 23, 2023
SELL
$434.7 - $599.3 $80.2 Million - $111 Million
-184,609 Reduced 18.25%
827,072 $444 Million
Q2 2023

Jul 24, 2023
BUY
$350.74 - $468.98 $39.9 Million - $53.3 Million
113,735 Added 12.67%
1,011,681 $474 Million
Q1 2023

May 03, 2023
SELL
$310.63 - $364.82 $63.7 Million - $74.8 Million
-205,102 Reduced 18.59%
897,946 $308 Million
Q4 2022

Feb 06, 2023
SELL
$321.55 - $374.67 $105 Million - $122 Million
-326,481 Reduced 22.84%
1,103,048 $404 Million
Q3 2022

Dec 01, 2022
BUY
$296.48 - $337.87 $13.6 Million - $15.5 Million
45,856 Added 3.31%
1,429,529 $462 Million
Q3 2022

Oct 26, 2022
BUY
$296.48 - $337.87 $13.6 Million - $15.5 Million
45,856 Added 3.31%
1,429,529 $462 Million
Q2 2022

Dec 01, 2022
SELL
$278.73 - $327.27 $27.2 Million - $31.9 Million
-97,607 Reduced 6.59%
1,383,673 $449 Million
Q2 2022

Jul 27, 2022
SELL
$278.73 - $327.27 $27.2 Million - $31.9 Million
-97,607 Reduced 6.59%
1,383,673 $449 Million
Q1 2022

Dec 01, 2022
SELL
$234.69 - $291.66 $15.6 Million - $19.4 Million
-66,502 Reduced 4.3%
1,481,280 $424 Million
Q1 2022

Apr 26, 2022
SELL
$234.69 - $291.66 $15.6 Million - $19.4 Million
-66,502 Reduced 4.3%
1,481,280 $424 Million
Q4 2021

Dec 01, 2022
SELL
$224.85 - $279.04 $80 Million - $99.3 Million
-355,909 Reduced 18.7%
1,547,782 $428 Million
Q4 2021

Jan 31, 2022
SELL
$224.85 - $279.04 $80 Million - $99.3 Million
-355,909 Reduced 18.7%
1,547,782 $428 Million
Q3 2021

Dec 01, 2022
SELL
$221.6 - $272.71 $26.2 Million - $32.3 Million
-118,379 Reduced 5.85%
1,903,691 $440 Million
Q3 2021

Oct 20, 2021
SELL
$221.6 - $272.71 $26.2 Million - $32.3 Million
-118,379 Reduced 5.85%
1,903,691 $440 Million
Q2 2021

Dec 01, 2022
SELL
$180.55 - $233.54 $17.7 Million - $22.9 Million
-97,888 Reduced 4.62%
2,022,070 $464 Million
Q2 2021

Jul 28, 2021
SELL
$180.55 - $233.54 $17.7 Million - $22.9 Million
-97,888 Reduced 4.62%
2,022,070 $464 Million
Q1 2021

Dec 01, 2022
BUY
$164.32 - $212.72 $113 Million - $147 Million
690,429 Added 48.3%
2,119,958 $396 Million
Q1 2021

Apr 23, 2021
SELL
$164.32 - $212.72 $87.1 Million - $113 Million
-530,302 Reduced 20.01%
2,119,958 $396 Million
Q4 2020

Dec 01, 2022
BUY
$130.46 - $172.63 $159 Million - $211 Million
1,220,731 Added 85.39%
2,650,260 $447 Million
Q4 2020

Jan 28, 2021
SELL
$130.46 - $172.63 $1.25 Million - $1.65 Million
-9,569 Reduced 0.36%
2,650,260 $447 Million
Q3 2020

Oct 29, 2020
BUY
$146.22 - $169.13 $10.6 Million - $12.3 Million
72,670 Added 2.81%
2,659,829 $394 Million
Q2 2020

Jul 20, 2020
BUY
$136.42 - $164.18 $133 Million - $160 Million
977,263 Added 60.7%
2,587,159 $425 Million
Q1 2020

Apr 30, 2020
BUY
$119.05 - $147.35 $6.29 Million - $7.78 Million
52,827 Added 3.39%
1,609,896 $223 Million
Q4 2019

Feb 06, 2020
BUY
$106.92 - $132.43 $34.9 Million - $43.3 Million
326,851 Added 26.57%
1,557,069 $205 Million
Q3 2019

Oct 17, 2019
BUY
$106.79 - $116.16 $21.4 Million - $23.3 Million
200,655 Added 19.49%
1,230,218 $138 Million
Q2 2019

Jul 19, 2019
BUY
$110.79 - $129.32 $25.6 Million - $29.9 Million
231,072 Added 28.94%
1,029,563 $114 Million
Q1 2019

May 02, 2019
BUY
$111.31 - $131.02 $17.1 Million - $20.2 Million
153,824 Added 23.86%
798,491 $104 Million
Q4 2018

Feb 08, 2019
BUY
$105.9 - $118.64 $14.4 Million - $16.1 Million
135,853 Added 26.7%
644,667 $74.5 Million
Q3 2018

Oct 31, 2018
BUY
$85.86 - $107.31 $71,349 - $89,174
831 Added 0.16%
508,814 $54.6 Million
Q3 2018

Oct 25, 2018
BUY
$85.86 - $107.31 $5.99 Million - $7.49 Million
69,758 Added 15.92%
507,983 $54.5 Million
Q2 2018

Aug 03, 2018
SELL
$75.7 - $86.88 $2.15 Million - $2.47 Million
-28,387 Reduced 6.08%
438,225 $37.4 Million
Q1 2018

May 07, 2018
BUY
$74.21 - $87.6 $5.08 Million - $5.99 Million
68,417 Added 17.18%
466,612 $36.1 Million
Q4 2017

Jan 25, 2018
BUY
$81.94 - $87.89 $13.7 Million - $14.7 Million
167,523 Added 72.62%
398,195 $33.6 Million
Q3 2017

Oct 17, 2017
BUY
$77.07 - $85.54 $25,510 - $28,313
331 Added 0.14%
230,672 $19.7 Million
Q2 2017

Aug 08, 2017
BUY
N/A
29,478 Added 14.68%
230,341 $19 Million
Q1 2017

Jan 19, 2021
BUY
N/A
200,863
200,863 $16.9 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email